Synapse

← Jurriën M. ten Berg

Papers by Jurriën M. ten Berg

Page 4 · newest first

  1. Incidence and outcome of prosthetic valve endocarditis after transcatheter aortic valve replacement in the NetherlandsNetherlands Heart Journal · 2020
  2. Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary InterventionCirculation Cardiovascular Interventions · 2020
  3. Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve ImplantationNew England Journal of Medicine · 2020
  4. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionJAMA Cardiology · 2020
  5. Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-UpJournal of Interventional Cardiology · 2020
  6. Late onset of new conduction disturbances requiring permanent pacemaker implantation following TAVIHeart · 2020
  7. Genotype-Guided Treatment of Oral P2Y ₁₂ Inhibitors: Where do we Stand?Pharmacogenomics · 2020
  8. Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)The American Journal of Cardiology · 2019
  9. Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trialCatheterization and Cardiovascular Interventions · 2019
  10. Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working groupNetherlands Heart Journal · 2019
  11. Indications for an early invasive strategy in NSTE-ACS patientsNetherlands Heart Journal · 2019
  12. Reasons for early discontinuing or switching of antiplatelet therapy in elderly patients after acute coronary syndromeCoronary Artery Disease · 2019
  13. A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCINew England Journal of Medicine · 2019
  14. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular trapsBlood · 2019
  15. Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2019
  16. Alcohol septal ablation in patients with severe septal hypertrophyHeart · 2019
  17. Measuring high on-treatment platelet reactivity in clinical practice; should we use a panel of platelet function tests?Blood Coagulation & Fibrinolysis · 2019
  18. Is there a place for heart-type fatty acid binding protein in the era of high-sensitive cardiac troponin T for the diagnosis of acute myocardial infarction? A systematic reviewEmergency Care Journal · 2019
  19. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionJAMA Cardiology · 2019
  20. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trialCatheterization and Cardiovascular Interventions · 2019
  21. Veno arterial-extra corporal membrane oxygenation for the treatment of cardiac failure in patients with infective endocarditisPerfusion · 2019
  22. Sex differences in characteristics and outcome in acute coronary syndrome patients in the NetherlandsNetherlands Heart Journal · 2019
  23. A “minimalistic hybrid algorithm” in coronary chronic total occlusion revascularization: Procedural and clinical outcomesCatheterization and Cardiovascular Interventions · 2019
  24. Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysisEuropean Heart Journal · 2019
  25. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trialEuropean Heart Journal · 2019
  26. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary interventionCardiovascular Research · 2019
  27. Antithrombotic Therapy After Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2019
  28. Effect of early tirofiban administration on N‐terminal pro‐B‐type natriuretic peptide level in patients treated with primary percutaneous coronary interventionCatheterization and Cardiovascular Interventions · 2018
  29. Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient‐years of follow upCatheterization and Cardiovascular Interventions · 2018
  30. Perioperative point of care platelet function testing and postoperative blood loss in high-risk cardiac surgery patientsPlatelets · 2018
  31. Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: insights from the Euro-ASA registryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2018
  32. Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of TreatmentTH Open · 2018
  33. Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysisEuroIntervention · 2018
  34. Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the NetherlandsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2018
  35. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)EP Europace · 2018
  36. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working groupNetherlands Heart Journal · 2018
  37. Neoatherosclerosis in Patients With Coronary Stent ThrombosisJACC: Cardiovascular Interventions · 2018
  38. Platelet Inhibition and Bleeding Risks in Patients Undergoing Non-Cardiac SurgeryThrombosis and Haemostasis · 2018
  39. A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatmentNetherlands Heart Journal · 2018
  40. Optimal treatment of patients with NSTE-ACS in the Dutch health care systemNetherlands Heart Journal · 2018
  41. Feasibility and Implementation of CYP2C19 Genotyping in Patients Using Antiplatelet TherapyPharmacogenomics · 2018
  42. Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trialsEuropean Heart Journal · 2018
  43. A clinical risk score to identify patients at high risk of very late stent thrombosisJournal of Interventional Cardiology · 2018
  44. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on ThrombosisEuropean Heart Journal · 2018
  45. First report of the use of long‐tapered sirolimus‐eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithmCatheterization and Cardiovascular Interventions · 2018
  46. Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarctionNetherlands Heart Journal · 2017
  47. Percutaneous closure of a patent foramen ovale after cryptogenic strokeNetherlands Heart Journal · 2017
  48. Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin TherapyCirculation · 2017
  49. Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablationEP Europace · 2017
  50. Feasibility of multiplane microtransoesophageal echocardiographic guidance in structural heart disease transcatheter interventions in adultsNetherlands Heart Journal · 2017